Neoplasia/BPH

	Potential Anticancer Effects of Limonene Associated with Reactive Oxygen Species Generation, Apoptosis Induction, and NF-ÎºB Modulation in Papillary Renal Cell Carcinoma: A Preliminary Study. Curr Dev Nutr Ghanbari M, Deyhimfar R, Khatami F, Haghani I, Menbari Oskouie I, Khoshchehreh M, Kazem Aghamir SM. PMID: 42388892 [PubMed]
	Urban residents' health literacy of four major cancers: a cross-sectional national survey. Front Public Health Lyu Y, Guo W, Wang Z, Paterson C, Lin F. PMID: 42388744 [PubMed - indexed for MEDLINE]
	Cuproptosis and prostate cancer: from molecular mechanisms and microenvironment remodeling to precision therapy. Front Oncol Tang Z, Shen S, Guo C, Chen A, Yang D, Sun J, Mi Y. PMID: 42388635 [PubMed]
	Comparative effectiveness and integrated safety of goserelin sustained-release microspheres versus implants in prostate cancer: a patient-based real-world study and systematic review with meta-analysis. Front Oncol Zhao J, Zhao Q, Liu X, Hou K, Chen Y, Lan H, Ping Y. PMID: 42388614 [PubMed]
	An exploratory study of BLCA-4 expression, STR analysis, and urothelial cytology in smokers versus non-smokers with bladder cancer. Front Oncol Momenah MA, Al-Qahtani WS. PMID: 42388612 [PubMed]
	Optimized Prostate Cancer Stage Classification Using XGBoost Based on Racial miRNA Expression. Cancer Diagn Progn Syechlo J, Agustriawan D, Kurniawan V, Mulia A, Wijaya EB, Nurdiansyah R, Kristiyanti DA, Wardhana AK. PMID: 42388593 [PubMed]
	The Impact of Comprehensive Panel NGS Testing and Cascade Family Screening on Early Diagnosis of Prostate Cancer and MINAS (ATM+MITF) Management. Cancer Diagn Progn Bilgetekin I, Bahsi T, Bahap Y, Ergün MA, Güllü I. PMID: 42388578 [PubMed]
	Prostate cancer: Value of the PI-FAB score and volume-adjusted PSA density in recurrence assessment after HIFU. Eur J Radiol Open Elsner C, Pausch AM, Rabadi T, Borde T, Rupp NJ, Eberli D, Mortezavi A, Heinz P, Held U, Hötker AM. PMID: 42388516 [PubMed]
	Diagnosis and Reporting of Intraductal Carcinoma of the Prostate: A Guide for Practising Pathologists With Excerpts From the Genitourinary Pathology Society and the International Society of Urological Pathology Joint Expert Consultation. Adv Anat Pathol Shah RB, Varma M, Zhou M, Paner GP, Kristiansen G. PMID: 42388176 [PubMed - as supplied by publisher]
	A Quantitative Modification of VI-RADS for Bladder Cancer at the Ureteral Orifice: A Reader Study on MRI With Varying Experience Levels. J Magn Reson Imaging Guo E, Chen L, Li Y, Fan P, Xie Y, Fan X, Ma L, Li X, Yang Y, Huang H, Xu L, Sun H, Zhang G. PMID: 42388066 [PubMed - as supplied by publisher]
	The financial impact of surgical interventions for benign prostatic hyperplasia within a single NHS trust. J Med Econ Sarna S, Ranasinghe S, Boaz RJ, Rochester M. PMID: 42387670 [PubMed - indexed for MEDLINE]
	Evaluation and analysis of renal injury in patients with advanced renal cell carcinoma receiving first-line benmelstobart plus anlotinib: results from the ETER100 study. BMC Med Li J, Tian H, Xu H, Yan X, Tang B, Li S, Zhou L, Wu X, Chi Z, Cui C, Si L, Guo J, Sheng X. PMID: 42387482 [PubMed - as supplied by publisher]
	The impact of abiraterone and enzalutamide on hypokalemia incidence in patients with prostate cancer: a systematic review and meta-analysis. BMC Cancer Lou Y, Fan D, Chen T, Xiong K. PMID: 42387420 [PubMed - indexed for MEDLINE]
	An AI-Driven Multi-Omics Framework Identifies CASP8 as a Clinically Actionable Pyroptosis Biomarker in Bladder Cancer. Biofactors Chen Z, Wang S, Sun Z, Liao H, Longji Y, Zhang Q, Wang J. PMID: 42387317 [PubMed - indexed for MEDLINE]
	A Core Outcome Set for Localized Renal Cell Cancer (L-RCC-COS). Eur Urol Focus Lawlor A, Van Hemelrijck M, Moss C, Tripathee S, Wintner LM, Marconi L, Bex A, Giles RH, Woodward R, Dabestani S, van den Brink L, Beyer K, Smith E, Ribal MJ, Campi R, Warren H, Tran M, Walkden M, Laird A, Stewart GD, Klatte T, Capitanio U, Heer R, Beisland C, Bonn SE, Albiges L, Zondervan P, MacLennan S. PMID: 42386478 [PubMed - as supplied by publisher]
	Cardiovascular complications of antineoplastic treatment in prostate cancer patients and compensatory strategies for clinical management. Eur J Intern Med Tsiamis N, Toulgaridis F, Stefanou E, Tountas C, Tsitsinakis G, Ballas E, Maurogenis I, Kitsiou A, Kole C. PMID: 42386405 [PubMed - as supplied by publisher]
	Re: McKay RR, Pal S, Xie W, et al. Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert Consensus on the Management of Renal Cell and Urinary Tract Cancers. CA Cancer J Clin 2026;76:e70052. Eur Urol Lorenzo GD, Maio MD. PMID: 42386399 [PubMed - as supplied by publisher]
	Long-term follow-up from the OMNIVORE trial: response-adaptive nivolumab and ipilimumab in advanced renal cell carcinoma. J Immunother Cancer McKay RR, Serzan M, Xie W, McGregor BA, Braun D, Wei X, Kyriakopoulos C, Zakharia Y, Maughan BL, Rose T, Stadler WM, Mcdermott DF, Choueiri TK. PMID: 42386345 [PubMed - indexed for MEDLINE]
	Incidental Renal Cell Carcinoma in an Active-Duty Fighter Pilot. Aerosp Med Hum Perform Woodside S, Nguyen D, Smith J, Udy A, Whetstone T, Zhang J. PMID: 42386197 [PubMed - indexed for MEDLINE]
	Circulating Tumor DNA After Radical Cystectomy as a Marker of Minimal Residual Disease in Muscle-Invasive Bladder Cancer: A Literature Review. Clin Genitourin Cancer Rodríguez-Parras P, Ángel Arrabal-Polo M, Arrabal-Martín M. PMID: 42385473 [PubMed - as supplied by publisher]

Articles 1 - 20 / 189382

Page 1 of 9470



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy